Use of bladder dose points for assessment of the spatial dose distribution in the posterior bladder wall in cervical cancer brachytherapy and the impact of applicator position

被引:12
|
作者
Nkiwane, Karen S. [1 ]
Poetter, Richard [1 ]
Fokdal, Lars U. [2 ]
Hoskin, Peter [3 ]
Pearcey, Robert [4 ]
Segedin, Barbara [5 ]
Mahantshetty, Umesh [6 ]
Kirisits, Christian [1 ]
机构
[1] Med Univ Vienna, Ctr Comprehens Canc, Dept Radiotherapy, A-1090 Vienna, Austria
[2] Aarhus Univ Hosp, Dept Oncol, DK-8000 Aarhus, Denmark
[3] Mt Vernon Hosp, Northwood HA6 2RN, Middx, England
[4] Univ Alberta, Cross Canc Inst, Edmonton, AB, Canada
[5] Inst Oncol Ljubljana, Dept Oncol, Ljubljana, Slovenia
[6] Tata Mem Hosp, Dept Radiat Oncol, Mumbai 400012, Maharashtra, India
基金
奥地利科学基金会;
关键词
Brachytherapy; Cervical cancer; 3D MRI; Bladder D-2cc; Applicator position; IMAGE-GUIDED BRACHYTHERAPY; INTRACAVITARY BRACHYTHERAPY; VOLUME PARAMETERS; ADAPTIVE BRACHYTHERAPY; RECOMMENDATIONS; RADIOTHERAPY; RECTUM; DISTENSION; CARCINOMA; PATTERNS;
D O I
10.1016/j.brachy.2014.11.006
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
PURPOSE: To validate the feasibility and use of dose points to characterize the bladder wall dose distribution and investigate potential impact of the applicator position in cervical cancer brachytherapy. METHODS AND MATERIALS: One hundred twenty-eight optimized MRI plans were evaluated. The International Commission of Radiation Units and Measurements (ICRU-38) point doses (Brow), surrogate for bladder base doses, were compared with D-2cc. Vaginal source to superior-anterior border of the symphysis distances were measured and compared within two groups, namely Group 1-B-ICRU/D-2cc >= 1 and Group 2-B-ICRU/D-2cc <1. Additionally, points at 1.5 and 2 cm cranial to the B-ICRU, parallel to the tandem and the body axis were analyzed. RESULTS: Thirty-seven percent of the patients had the ratio B-ICRU/D-2cc of 1 or higher, with the 2cc subvolume at the bladder base (Group 1). In 63%, B-ICRU/D-2cc, ratio was lower than 1 and the 2cc, cranial to the bladder base (Group 2). Median vaginal source-to-superior anterior border of the symphysis line distance was -2 cm (range, -3.7 to + 1.2 cm) in Group 1 and +1.8 cm (range, -2 to +4.8 cm) in Group 2 (+ cranial/- caudal direction). There was a high correlation between vaginal sources near the symphysis and the 2cc subvolume at the bladder base. The additional points provided no added value. CONCLUSIONS: Location of the 2cc subvolume varies in cervical cancer brachytherapy. Maximum doses are at the bladder base if vaginal sources are also in the vicinity of the bladder base indicated by B-ICRU/D-2cc ratio of 1 or higher. Such variation should be considered in dose-effect analyses and intercomparisons, as the same D-2cc at different bladder locations may correlate with different morbidity profiles and severity Reporting D-2cc and B-ICRU doses together therefore remains essential. (C) 2015 American Brachytherapy Society. Published by Elsevier Inc. All rights reserved.
引用
收藏
页码:252 / 259
页数:8
相关论文
共 50 条
  • [31] Rectal and bladder dose reduction with the addition of intravaginal balloons to vaginal packing in intracavitary brachytherapy for cervical cancer
    Eng, T. Y.
    Patel, A. J.
    Ha, C. S.
    BRACHYTHERAPY, 2016, 15 (03) : 312 - 318
  • [32] Inter-application displacement of brachytherapy dose received by the bladder and rectum of the patients with inoperable cervical cancer
    Marosevic, Goran
    Ljuca, Dzenita
    Osmic, Hasan
    Fazlic, Semir
    Arsovski, Oliver
    Mileusnic, Dusan
    RADIOLOGY AND ONCOLOGY, 2014, 48 (02) : 203 - 209
  • [33] Intrafractional applicator shifts in MRI adaptive high dose rate brachytherapy for cervical cancer
    Lapuz, C.
    Hanna, S.
    Ong, W. L.
    Lim, A.
    RADIOTHERAPY AND ONCOLOGY, 2018, 127 : S1228 - S1228
  • [34] Study of factors influencing dose distribution of brachytherapy in cervical cancer
    刘孜
    高莹
    罗伟
    王国庆
    王蕊花
    郑伟
    刘锐
    Academic Journal of Xi'an Jiaotong University, 2008, (02) : 125 - 127
  • [35] Computer tomography-assisted three-dimensional technique to assess rectal and bladder wall dose in intracavitary brachytherapy for uterine cervical cancer
    Sun, LM
    Huang, EY
    Ko, SF
    Wang, CJ
    Leung, SW
    Lin, H
    Wu, JM
    Wu, IH
    Lee, SP
    RADIOTHERAPY AND ONCOLOGY, 2004, 71 (03) : 333 - 337
  • [36] DOSE DISTRIBUTION IN BLADDER AND SURROUNDING NORMAL TISSUES IN RELATION TO BLADDER VOLUME IN CONFORMAL RADIOTHERAPY FOR BLADDER CANCER
    Majewski, Wojciech
    Wesolowska, Iwona
    Urbanczyk, Hubert
    Hawrylewicz, Leszek
    Schwierczok, Barbara
    Miszczyk, Leszek
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2009, 75 (05): : 1371 - 1378
  • [37] Attention 3D U-NET for dose distribution prediction of high-dose-rate brachytherapy of cervical cancer: Direction modulated brachytherapy tandem applicator
    Gautam, Suman
    Osman, Alexander F. I.
    Richeson, Dylan
    Gholami, Somayeh
    Manandhar, Binod
    Alam, Sharmin
    Song, William Y.
    MEDICAL PHYSICS, 2024, 51 (08) : 5593 - 5603
  • [38] Evaluating the Impact of Bladder Filling Status for the Organs at Risk Dose Distribution in Cervical Cancer Patients with Intensity Modulated Radiotherapy
    Zhang, J. Y.
    Hong, D. L.
    MEDICAL PHYSICS, 2016, 43 (06) : 3554 - 3554
  • [39] The impact of the bladder volume on the dose to organs at risk dosimetry of vaginal vault brachytherapy
    Hadhemi, Ayadi
    Hajer, Jaffel
    Samia, Ben Hssine
    Takoua, Ben Dhif
    Radhouane, Braiki
    Wiem, Abid
    Manel, Arfaoui
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2024, 34 (SUPPL_1) : A195 - A195
  • [40] Optimal bladder filling during high-dose-rate intracavitary brachytherapy for cervical cancer: a dosimetric study
    Mahantshetty, Umesh
    Shetty, Saurabha
    Majumder, Dipanjan
    Adurkar, Pranjal
    Swamidas, Jamema
    Engineer, Reena
    Chopra, Supriya
    Shrivastava, Shyamkishore
    JOURNAL OF CONTEMPORARY BRACHYTHERAPY, 2017, 9 (02) : 112 - 117